Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Procter & Gamble Opens New Chapter With Supplement Deal

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble buys Vermont-based whole foods supplement maker New Chapter Organics, expanding its consumer business and gaining a foothold in the natural products space. P&G intends to keep New Chapter a wholly owned subsidiary and leave most of its operations intact.

You may also be interested in...



New Chapter Founders' Vision Limited, Voice Stifled Under Parent Firm P&G

New Chapter founders Paul and Barbi Schulick leave and sever ties with parent firm Procter & Gamble six years after their company providing herbal products to US health food and vitamin stores was acquired by the global consumer health, personal and household care products marketer. Nature's Bounty adds Don Kerrigan, formerly in charge of US OTC drug marketing for Bayer and Pfizer, as its president for North America.

P&G Considering “Value-Driven” Consumer Health Opportunities

Procter & Gamble says consumer health is “a space that we like” for mergers and acquisitions or organic growth, even though sales for the firm’s health care segment slumped 2% in its latest quarter. A financial analyst expects news this year on who will succeed CEO A.G. Lafley.

P&G Considering “Value-Driven” Consumer Health Opportunities

Procter & Gamble says consumer health is “a space that we like” for mergers and acquisitions or organic growth, even though sales for the firm’s health care segment slumped 2% in its latest quarter. A financial analyst expects news this year on who will succeed CEO A.G. Lafley.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel